Cassava Sciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SAVA and other ETFs, options, and stocks.

About SAVA

Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. 

CEO
Richard Jon Barry
CEORichard Jon Barry
Employees
30
Employees30
Headquarters
Austin, Texas
HeadquartersAustin, Texas
Founded
1998
Founded1998
Employees
30
Employees30

SAVA Key Statistics

Market cap
89.85M
Market cap89.85M
Price-Earnings ratio
-1.25
Price-Earnings ratio-1.25
Dividend yield
—
Dividend yield—
Average volume
804.12K
Average volume804.12K
High today
$1.91
High today$1.91
Low today
$1.84
Low today$1.84
Open price
$1.89
Open price$1.89
Volume
90.20K
Volume90.20K
52 Week high
$42.20
52 Week high$42.20
52 Week low
$1.15
52 Week low$1.15

People also own

Based on the portfolios of people who own SAVA. This list is generated using Robinhood data, and it’s not a recommendation.
NIO
Lucid Group
AMC Entertainment
Ocugen, Inc
Plug Power
MARA Holdings
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.